首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

【2h】

Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

机译：健康保险体系视角下阿帕替尼治疗晚期转移性胃癌的成本效果和预算影响分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective This study evaluated the cost-effectiveness of apatinib in patients with chemotherapy-refractory mGC.

机译：目的评估阿帕替尼在化疗难治性mGC患者中的成本效益。

著录项

期刊名称 Gastroenterology Research and Practice
作者
Yongrui Bai; Yuejuan Xu; Bin Wu;
展开▼
作者单位

展开▼
年(卷),期 2017(2017),-1
年度 2017
页码 2816737
总页数 7
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System [J] . Bai Yongrui, Xu Yuejuan, Wu Bin Gastroenterology research and practice . 2017,第Pta3期

机译：从健康保险制度看高级转移性胃癌的阿凡蛋白成本效益和预算分析
2. Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System [J] . Yongrui Bai, Yuejuan Xu, Bin Wu, Gastroenterology research and practice . 2017,第Pta1期

机译：从健康保险制度看高级转移性胃癌的阿凡蛋白成本效益和预算分析
3. CHOOSING FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER BASED ON BIOMARKER RAS STATUS: A BUDGET IMPACT ANALYSIS FROM BRAZILIAN HEALTH INSURANCE SYSTEM PERSPECTIVE [J] . Souza P. V, Simoes A. C., Zanini F. E. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：基于生物标志物RAS状态选择转移性大肠癌一线治疗：巴西健康保险体系的预算影响分析
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Cervical Cancer in Low-Income Settings: Costs, Cost-effectiveness, and Budget Impact of Integrating Screening and Treatment into Existing Health Systems in East Africa [D] . Vodicka, Elisabeth. 2018

机译：低收入地区的宫颈癌：将筛查和治疗纳入东非现有卫生系统的费用，成本效益和预算影响
6. Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives [O] . Thitima Kongnakorn, Murtuza Bharmal, Mairead Kearney, 2019

机译：在美国将Avelumab纳入二线治疗局部晚期或转移性尿道癌的预算影响：商业和医疗保险付款人观点
7. PCN132 ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX®) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO [O] . F. Carlos, J. Guzmán, M. Naranjo, 2019

机译：PCN132氟斯特语（Faslodex®）在未接受墨西哥公共医疗系统的角度下未接受先前内分泌治疗的绝经后妇女治疗局部晚期或转移性乳腺癌的经济评估和预算影响

Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

摘要

著录项

相似文献

相关主题

期刊订阅